AbbVie (ABBV) Dividends payables (2013 - 2015)

AbbVie has disclosed Dividends payables across 3 years of filings, most recently posting $924.0 million for Q4 2015.

• In Q4 2015, Dividends payables rose 16.81% year-over-year to $924.0 million; the TTM figure through Dec 2015 stood at $924.0 million (up 16.81% YoY), while the FY2015 annual figure was $924.0 million, up 16.81% from the prior year.
• Dividends payables climbed to $924.0 million in Q4 2015, from $791.0 million in the prior quarter.
• Over the last five years, Dividends payables for ABBV reached as high as $924.0 million in Q4 2015 and fell as low as $643.0 million in Q4 2013.
• The 3-year median for Dividends payables is $791.0 million (2014), against an average of $786.0 million.
• Annual changes were most pronounced in 2014 — Dividends payables climbed 23.02% — and 2015, when it climbed 16.81%.
• A 3-year view of Dividends payables shows it stood at $643.0 million in 2013, then rose by 23.02% to $791.0 million in 2014, then rose by 16.81% to $924.0 million in 2015.
• According to Business Quant data, Dividends payables over the past three periods registered $924.0 million, $791.0 million, and $643.0 million for Q4 2015, Q4 2014, and Q4 2013 respectively.